(E)-4-(Prop-1-en-2-yl)cyclohex-1-enecarbaldehyde oxime, 98.0%, 100g

((S)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL)METHYL 3-(4-((S)-2-HYDROXY-3-((2-(MORPHOLINE-4-CARBOXAMIDO)ETHYL)AMINO)PROPOXY)PHENYL)PROPANOATE HCL, 97%, 50mg

7-Fluoro-1,2,3,4-tetrahydroquinoline, 97%, 250mg

(3-Bromophenyl)diphenylphosphine Oxide>98.0%(GC)200mg

Methyl 5-bromo-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxylate, 98%, 100mg

tert-Butyl ((2S,3R)-2-methylpiperidin-3-yl)carbamate, 95%, 500mg

N-(5-BROMOIMIDAZO[1,2-A]PYRIDIN-2-YL)-2,2,2-TRIFLUOROACETAMIDE, 95.0%, 1g

(5ALPHA)-ESTRANE-3,17-DIONE, 95%, 1g

Benazepril hydrochloride, 99%, 250mg

Papeleras Sharpsafe® de gran volumen, 24 l, 1 pieza

tert-butyl 3-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 500mg

(S)-2-(benzyl(methyl)amino)-4-fluoro-4-methylpentanoic acid, 97%, 50mg

methyl 3-{[(furan-2-yl)methyl]amino}-2-methylpropanoate, 95.0%, 10g